RAPT Therapeutics Announces Two FLX475 Presentations at the Society for Immunotherapy of Cancer ...

SOUTH SAN FRANCISCO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies

Related Keywords

San Diego ,California ,United States ,San Diego Convention Center ,Aljanae Reynolds ,Sylvia Wheeler ,Society For Immunotherapy Of Cancer ,Therapeutics Inc ,Nasdaq ,San Diego Convention ,Region ,